The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intismeran autogene to induce de novo neoantigen-specific T cells as adjuvant therapy in melanoma.
 
Ryan Sullivan
Consulting or Advisory Role - BridGene Biosciences; Bristol-Myers Squibb; Marengo Therapeutics; Merck; Novartis; Pfizer; PharmaMar; Replimune
Research Funding - BeiGene (Inst); BioMed Valley Discoveries (Inst); BioNTech SE (Inst); Compugen (Inst); Georgimmune (Inst); Marengo Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics (Inst); Sanofi (Inst); Strategia (Inst); Synthekine (Inst)
 
Matteo Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; IDEAYA Biosciences; Innovent Biologics; Medison; Medison; Merck Serono; Moderna Therapeutics; MSD; Nektar; Novartis; OncoSec; Pierre Fabre; QBiotics; Regeneron; Roche; Sanofi; Strand Therapeutics
 
Muhammad Khattak
Honoraria - Evaxion Biotech
Consulting or Advisory Role - Moderna Therapeutics
Travel, Accommodations, Expenses - Evaxion Biotech; Moderna Therapeutics; Pierre Fabre
 
Georgina Long
Honoraria - BMS; Pierre Fabre
Consulting or Advisory Role - Agenus; AstraZeneca; AstraZeneca/UK; Aulos Bioscience; Bayer; BioNTech SE; Boehringer Ingelheim; Bristol Myers Squibb; Byondis; Evaxion Biotech; GI Innovation Inc; Hexal; Highlight Therapeutics; Immunocore Ireland Limited; Innovent Biologics; IO Biotech; Iovance Biotherapeutics; Merck Sharp & Dohme; Novartis; OncoSec; PHMR; Pierre Fabre; Regeneron; Scancell LImited; Skyline Diagnostics; Strand Therapeutics
 
Justin Gainor
Employment - Alkeus Pharmaceuticals (I); Ironwood Pharmaceuticals (I)
Leadership - AI Proteins, Inc
Stock and Other Ownership Interests - AI Proteins, Inc; Ironwood Pharmaceuticals (I)
Honoraria - BeiGene; Merck; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Arcus Biosciences; Array BioPharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Ellipses Pharma; EMD Serono; Genentech; Gilead Sciences; InterVenn Biosciences; ITeos Therapeutics; Lilly; Mariana Oncology; Merck; Merus; Mirati Therapeutics; Moderna Therapeutics; Novartis; Nuvalent, Inc.; Pfizer; Revolution Medicines; Sanofi; Silverback Therapeutics; Takeda; Tempus
Research Funding - Adaptimmune (Inst); Alexo Therapeutics (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Genentech; Jounce Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis; Novartis (Inst); Palleon Pharmaceuticals (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Manish Patel
Leadership - ION Pharma
Consulting or Advisory Role - Accutar Biotech; Daiichi Sankyo/UCB Japan; Johnson & Johnson/Janssen; Kura Oncology; Mitsubishi Tanabe Pharma; shivanka Research
Research Funding - Abbvie (Inst); Abdera Thereapeutics (Inst); Accutar Biotech (Inst); Adagene (Inst); Agenus (Inst); Allorion Therapeutics (Inst); Apollo (Inst); Artios (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Avenzo (Inst); BioNTech SE (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb/Celgene (Inst); Compugen (Inst); Conjupro Biotherapeutics (Inst); Cullinan Oncology (Inst); cyteir (Inst); D3 Bio (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Georgiamune (Inst); Hotspot Therapeutics (Inst); Immune-Onc Therapeutics (Inst); Immunitas (Inst); Immunogen (Inst); Incyte (Inst); Janssen (Inst); Kineta (Inst); Kura Oncology (Inst); Lilly (Inst); Loxo (Inst); Macrogenics (Inst); Medlink (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); nurix (Inst); Olema Oncology (Inst); OnCusp Therapeutics (Inst); Pfizer (Inst); Prelude Therapeutics (Inst); Ribon Therapeutics (Inst); Seven and Eight Biopharmaceuticals (Inst); Step Pharma (Inst); Sutro Biopharma (Inst); Syndax (Inst); Systimmune (Inst); TeneoBio (Inst); Vividion Therapeutics (Inst); Zai Lab (Inst); Zymeworks (Inst)
 
Jeffrey Clarke
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Corbus; G1 Therapeutics; Genentech; Merck; Novartis; Pfizer; Sanofi; Spectrum Pharmaceuticals; Turning Point Therapeutics; Vivacitas Oncology
Speakers' Bureau - Amgen; AstraZeneca
Research Funding - Achilles Therapeutics (Inst); Adaptimmune (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cellular Biomedicine Group (Inst); Genentech (Inst); Grid Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen
(OPTIONAL) Uncompensated Relationships - Lung Cancer Initiative of North Carolina
 
Tamara Ouspenskaia
Employment - Moderna Therapeutics
Stock and Other Ownership Interests - BioNTech SE; Moderna Therapeutics
Travel, Accommodations, Expenses - Moderna Therapeutics
 
Sai Kiran Sedimbi
Employment - Moderna Therapeutics
Stock and Other Ownership Interests - Intellia Therapeutics; Moderna Therapeutics; Summit Therapeutics
 
Joshua Araya
Employment - Moderna Therapeutics
Stock and Other Ownership Interests - Moderna Therapeutics
 
Vinod Krishna
Employment - Johnson & Johnson/Janssen; Moderna Therapeutics
Stock and Other Ownership Interests - Johnson & Johnson/Janssen; Lilly; Moderna Therapeutics; Novo Nordisk
Patents, Royalties, Other Intellectual Property - Author on patents pertaining to potential off-the shelf cancer vaccine and TCR therapies. Any potential royalties from these patents are assigned to my parent institution where the work was performed (J&J/Janssen). (Inst)
 
Cansu Tacettin
Employment - Moderna Therapeutics
Stock and Other Ownership Interests - Moderna Therapeutics
 
Andressa Laino
Employment - Moderna Therapeutics
Stock and Other Ownership Interests - Moderna Therapeutics
Research Funding - Moderna Therapeutics
Patents, Royalties, Other Intellectual Property - Employee at Moderna.
Travel, Accommodations, Expenses - Moderna Therapeutics
Other Relationship - Moderna Therapeutics
 
Rachael Aubin
Employment - Moderna Therapeutics
Stock and Other Ownership Interests - Moderna Therapeutics
Travel, Accommodations, Expenses - Moderna Therapeutics
 
Sheila Yee
Employment - Moderna Therapeutics
Stock and Other Ownership Interests - Moderna Therapeutics
Travel, Accommodations, Expenses - Moderna Therapeutics
 
Janice Mehnert
Stock and Other Ownership Interests - Pfizer
Honoraria - HMP; Medscape
Consulting or Advisory Role - Bristol-Myers Squibb; Cugene; Immunocore; Merck Sharp & Dohme; Moderna Therapeutics; Sanofi/Regeneron; Sun Pharma
Research Funding - Amgen (Inst); AstraZeneca (Inst); bristol myers squibb (Inst); Deciphera (Inst); GV20 Therapeutics; Incyte (Inst); Kinnate Biopharma (Inst); Merck (Inst); Nested Therapeutics; Novartis (Inst); Regeneron (Inst)